Russian opposition leader Navalny arrested upon arrival in Moscow

MOSCOW — Russian opposition leader Alexei Navalny was arrested upon arrival at a Moscow airport on Sunday, five months after being poisoned by a military-grade nerve agent.

Navalny had flown in from Berlin, where he had undergone treatment for exposure to the nerve agent Novichok. The anti-corruption crusader and European countries have blamed Russian authorities for the poisoning, which Moscow rejects.

Navalny was detained not long after his plane made a surprise detour from the airport where it was originally scheduled to land and where hundreds of his supporters had gathered to greet him, braving temperatures of -20 degrees Celsius. Around 60 supporters were arrested there.

Before being taken away by police at passport control, Navalny had told journalists he did not regret coming back to Russia, despite the known threat of arrest.

“I am completely happy,” he said. “This is the best day in five months.”



Source by [author_name]

Latest

Catalytic converter theft ring busted in Oregon; how to prevent theft

If your vehicle’s catalytic converter was one of 44,000...

Rival Shia groups square off over Iraq leadership vacuum

Rival Iraqi factions took to the streets of Baghdad...

EU proposes lifting pressure on Iran’s Revolutionary Guards to revive nuclear deal

Press play to listen to this article BERLIN — Europe’s...

NASA satellite captures Sahara Desert dust plume over the Atlantic Ocean

Dust clouds have never looked this good.July was a...

EU proposes lifting pressure on Iran’s Revolutionary Guards to revive nuclear deal

Press play to listen to this article BERLIN — Europe’s proposal to resuscitate Tehran’s nuclear deal with world powers would blunt American sanctions against Iran’s...

Author Salman Rushdie attacked on stage in New York

LONDON — Novelist Salman Rushdie has been violently attacked while delivering a lecture in New York. Police said Rushdie was airlifted to hospital after...

UK not buying AstraZeneca’s COVID-19 antibody drug over lack of data

The U.K. has no plans to buy doses of AstraZeneca’s COVID-19 antibody therapy Evusheld that is designed to protect vulnerable people, arguing that the...